Saturday 17 October 2026
Export PARK’s income statement to Excel — free account
Park Dental Partners, Inc.
PARK Healthcare Medical Care Facilities
Park Dental Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $244.5 million, up 6.40% from fiscal 2024. In the quarter to June 2026, revenue grew 12.2%, EPS fell 65.8% and free cash flow fell 34.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
18.95
0.26
−1.35%
Follow PARK
| Dec '25 | Dec '24 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 |
P/FCF ratio |
2.37 | 0.00 |
P/Operating CF |
2.08 | 5.39 |
Beneish M-Score |
(2.69) | — |
P/B ratio |
1.68 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
0.87 | 0.00 |
EV/FCF |
1.52 | 0.00 |
Quick Ratio |
0.98 | 0.33 |
Current Ratio |
1.06 | 0.40 |
Net Debt/EBITDA |
(1.37) | 0.64 |
Debt/Assets |
6.72% | 9.33% |
Debt/Equity |
0.55 | (3.23) |
Asset Turnover |
1.50 | 0.00 |
Operating CF/Net income |
(49.25) | 3.77 |
Capex/Depreciation |
(0.78) | (0.70) |
Interest Coverage |
0.21 | 5.98 |
| (4.09%) | 0.00% | |
| (0.22%) | 0.00% | |
ROIC |
1.82% | 78.23% |
Return on Tangible Assets |
(1.14%) | 38.14% |
Average Days of Receivables |
14.66 | 12.12 |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
13.05% | 11.08% |
Intangible Assets out of Total Assets |
0.16 | 0.19 |
Share Based Compensation of Revenue |
3.60% | 0.23% |
Graham Net Nets |
(3.23) | (7.74) |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(0.43%) | (0.43%) |
Free Cash Flow Yield |
42.23% | 0.00% |
Revenue per Share |
125.74 | 127.21 |
Operating CF per Share |
9.07 | 9.12 |
Capex per Share |
(3.78) | (3.41) |
Free Cash Flow per Share |
5.29 | 5.71 |
Cash per Share |
12.95 | 1.48 |
Shareholders Equity per Share |
11.21 | (2.38) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
11.21 | (2.38) |
Free Cash Flow |
10.29 | 10.31 |
Working Capital |
2.17 | (18.62) |
Capital Expenditures |
(7.34) | (6.15) |
Net Current Asset Value |
(118.48) | (140.59) |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.03 | 0.03 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
0.32 | 0.29 |
Cash ROIC |
17.45% | 84.08% |
Accounts Receivable Turnover |
28.02 | 0.00 |
Accounts Payable Turnover |
38.49 | 0.00 |
Inventory Turnover |
0.00 | 0.00 |
Average Days of Payables |
10.89 | 8.77 |
Days of Inventory on Hand |
0.00 | 0.00 |
Average Receivables |
8.73 | — |
Average Payables |
5.48 | — |
Average Assets |
163.53 | — |
Average Common Equity |
8.75 | — |
Columns are period end dates